|
1
|
Sun H, Li S, Yan Y, Chen Z, Wang Y, Hao C
and Ji W: Associations between patient clinical characteristics and
the presence of cytomegalovirus DNA in the bronchoalveolar lavage
fluid of children with recurrent wheezing. BMC Infect Dis.
18(458)2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Neant N, Klifa R, Bouazza N, Moshous D,
Neven B, Leruez-Ville M, Blanche S, Treluyer JM, Hirt D and Frange
P: Model of population pharmacokinetics of cidofovir in
immunocompromised children with cytomegalovirus and adenovirus
infection. J Antimicrob Chemother. 73:2422–2429. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gentile I, Zappulo E, Riccio MP, Binda S,
Bubba L, Pellegrinelli L, Scognamiglio D, Operto F, Margari L,
Borgia G and Bravaccio C: Prevalence of congenital cytomegalovirus
infection assessed through viral genome detection in dried blood
spots in children with autism spectrum disorders. In Vivo.
31:467–473. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Riga M, Korres G, Chouridis P, Naxakis S
and Danielides V: Congenital cytomegalovirus infection inducing
non-congenital sensorineural hearing loss during childhood; a
systematic review. Int J Pediatr Otorhinolaryngol. 115:156–164.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Palma S, Roversi MF, Bettini M, Mazzoni S,
Pietrosemoli P, Lucaccioni L, Berardi A and Genovese E: Hearing
loss in children with congenital cytomegalovirus infection: An
11-year retrospective study based on laboratory database of a
tertiary paediatric hospital. Acta Otorhinolaryngol Ital. 39:40–45.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ghorbani S, Mahdavi R, Alipoor B, Panahi
G, Nasli Esfahani E, Razi F, Taghikhani M and Meshkani R: Decreased
serum microRNA-21 level is associated with obesity in healthy and
type 2 diabetic subjects. Arch Physiol Biochem. 124:300–305.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gong YY, Luo JY, Wang L and Huang Y:
MicroRNAs regulating reactive oxygen species in cardiovascular
diseases. Antioxid Redox Signal. 29:1092–1107. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Belarbi Y, Mejhert N, Gao H, Arner P,
Rydén M and Kulyté A: MicroRNAs-361-5p and miR-574-5p associate
with human adipose morphology and regulate EBF1 expression in white
adipose tissue. Mol Cell Endocrinol. 472:50–56. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ding M, Wang X, Wang C, Liu X, Zen K, Wang
W, Zhang CY and Zhang C: Distinct expression profile of HCMV
encoded miRNAs in plasma from oral lichen planus patients. J Transl
Med. 15(133)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liang Q, Wang K, Wang B and Cai Q:
HCMV-encoded miR-UL112-3p promotes glioblastoma progression via
tumour suppressor candidate 3. Sci Rep. 7(44705)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Pan Y, Wang N, Zhou Z, Liang H, Pan C, Zhu
D, Liu F, Zhang CY, Zhang Y and Zen K: Circulating human
cytomegalovirus-encoded HCMV-miR-US4-1 as an indicator for
predicting the efficacy of IFNα treatment in chronic hepatitis B
patients. Sci Rep. 6(23007)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mukhopadhyay R, Roy S, Venkatadri R, Su
YP, Ye W, Barnaeva E, Mathews Griner L, Southall N, Hu X, Wang AQ,
et al: Efficacy and mechanism of action of low dose emetine against
human cytomegalovirus. PLoS Pathog. 12(e1005717)2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Aryal S, Katugaha SB, Cochrane A, Brown
AW, Nathan SD, Shlobin OA, Ahmad K, Marinak L, Chun J, Fregoso M,
et al: Single-center experience with use of letermovir for CMV
prophylaxis or treatment in thoracic organ transplant recipients.
Transpl Infect Dis. 21(e13166)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Li J, Pan CW, Zhou GY, Zhuge L, Fang PP,
Jin LX, Lin W, Lin XZ and Zheng Y: Studies on the interference of
ganciclovir to HCV liver fibrosis. Eur Rev Med Pharmacol Sci.
20:4343–4347. 2016.PubMed/NCBI
|
|
15
|
Kuwahara-Ota S, Chinen Y, Mizuno Y,
Takimoto-Shimomura T, Matsumura-Kimoto Y, Tanba K, Tsukamoto T,
Mizutani S, Shimura Y, Kobayashi T, et al: Human herpesvirus-6
pneumonitis in a patient with follicular lymphoma following
immunochemotherapy with rituximab. Infect Drug Resist. 11:701–705.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ju HY, Kang HJ, Hong CR, Lee JW, Kim H,
Park KD, Shin HY, Park JD, Choi EH, Lee HJ and Ahn HS: Half-dose
ganciclovir preemptive treatment of cytomegalovirus infection after
pediatric allogeneic hematopoietic stem cell transplantation.
Transpl Infect Dis. 18:396–404. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Liu LW, Qian JH, Zhu TW, Zhang YH and Zhu
JX: A 5-year retrospective clinical study of perinatal
cytomegalovirus infection. Zhongguo Dang Dai Er Ke Za Zhi.
18:99–104. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
18
|
Yin CM, Suen WC, Lin S, Wu XM, Li G and
Pan XH: Dysregulation of both miR-140-3p and miR-140-5p in synovial
fluid correlate with osteoarthritis severity. Bone Joint Res.
6:612–618. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kasmapour B, Kubsch T, Rand U, Eiz-Vesper
B, Messerle M, Vondran FWR, Wiegmann B, Haverich A and Cicin-Sain
L: Myeloid dendritic cells repress human cytomegalovirus gene
expression and spread by releasing interferon-unrelated soluble
antiviral factors. J Virol. 92:e01138–17. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Piret J and Boivin G: Clinical development
of letermovir and maribavir: Overview of human cytomegalovirus drug
resistance. Antiviral Res. 163:91–105. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ye B and Zhao H: Early abnormal liver
enzyme levels may increase the prevalence of human cytomegalovirus
antigenaemia after hematopoietic stem cell transplantation. J Int
Med Res. 45:673–679. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Nolan N, Halai UA, Regunath H, Smith L,
Rojas-Moreno C and Salzer W: Primary cytomegalovirus infection in
immunocompetent adults in the United States-A case series. IDCases.
10:123–126. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ando G, Taguchi K, Enoki Y, Yokoyama Y,
Kizu J and Matsumoto K: Evaluation of the expression time of
ganciclovir-induced adverse events using JADER and FAERS. Biol
Pharm Bull. 42:1799–1804. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Imai S, Yamada T, Kasashi K, Ishiguro N,
Kobayashi M and Iseki K: Construction of a flow chart-like risk
prediction model of ganciclovir-induced neutropaenia including
severity grade: A data mining approach using decision tree. J Clin
Pharm Ther. 44:726–734. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhang J, Huang Y, Wang Q, Ma Y, Qi Y, Liu
Z, Deng J and Ruan Q: Levels of human cytomegalovirus miR-US25-1-5p
and miR-UL112-3p in serum extracellular vesicles from infants with
HCMV active infection are significantly correlated with liver
damage. Eur J Clin Microbiol Infect Dis. 39:471–481.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Landais I, Pelton C, Streblow D,
DeFilippis V, McWeeney S and Nelson JA: Human cytomegalovirus
miR-UL112-3p targets TLR2 and modulates the TLR2/IRAK1/NFκB
signaling pathway. PLoS Pathog. 11(e1004881)2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Britt WJ and Prichard MN: New therapies
for human cytomegalovirus infections. Antiviral Res. 159:153–174.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hahn F, Hutterer C, Henry C, Hamilton ST,
Strojan H, Kraut A, Schulte U, Schütz M, Kohrt S, Wangen C, et al:
Novel cytomegalovirus-inhibitory compounds of the class
pyrrolopyridines show a complex pattern of target binding that
suggests an unusual mechanism of antiviral activity. Antiviral Res.
159:84–94. 2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Andronova VL: Modern ethiotropic
chemotherapy of human cytomegalovirus infection: Clinical
effectiveness, molecular mechanism of action, drug resistance, new
trends and prospects. Part 1. Vopr Virusol. 63:202–211.
2018.PubMed/NCBI View Article : Google Scholar : (In Russian).
|
